ArticleJournal of orthopaedic case reports2026
Short-term Clinical Outcomes of Primary Total Hip Arthroplasty with the CoreHip Stem.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The CoreHip Stem is a novel femoral stem introduced in 2021. It features a triple-taper design that enables three-dimensional load transmission and provides high rotational stability due to its rectangular cross-sectional geometry. This study aimed to retrospectively review the short-term clinical outcomes of primary total hip arthroplasty (THA) using the CoreHip Stem. Materials and Methods: A total of 41 primary THA cases (17 men and 24 women; mean age, 66 years; mean follow-up period, 18 months) performed through a supine anterolateral approach at our institution between July 2024 and August 2025 were enrolled in this study. The evaluated parameters included operative time, intraoperative blood loss, the Japanese Orthopaedic Association (JOA) hip scores, perioperative complications, postoperative stem alignment, subsidence, stress shielding, spot welds, cortical hypertrophy, and radiolucent lines. Statistical analyses were performed using the t-test. Results: The mean operative time was 66.1 min, and the mean intraoperative blood loss was 202.2 mL. The mean JOA hip score improved from 44.9 points preoperatively to 95.2 points postoperatively. No perioperative complications were observed during the follow-up period. The stem survival rate was 100% at the final follow-up. No case showed obvious stem malalignment or subsidence of ≥2 mm. Grade I stress shielding was observed in five cases. Spot welds were identified in 30% of cases in Gruen zones 2 and 6 and in 27% of cases in zones 3 and 5. No other radiographic abnormalities were observed. Discussion: Past studies have shown favorable short- to mid-term clinical outcomes in THA cases using short tapered-wedge stems. The results of the present study were consistent with previous reports. Although the CoreHip Stem was originally designed to promote proximal bone ingrowth, distal spot welds were often observed in our cases. This finding may reflect strong distal fixation and reactive bone formation induced by the cancellous bone bed. In our experience, the CoreHip Stem is relatively easy to handle and has a wide range of clinical applications. Further long-term investigations are warranted to confirm our findings. Conclusion: The THA cases using the CoreHip Stem showed favorable short-term clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.